Related Experiment Videos
Covalent binding and endogenous incorporation as illustrated by nitroso carcinogens
Journal of Toxicology and Environmental Health
|March 1, 1977
Summary
Distinguishing radioactivity incorporation is crucial for drug safety evaluation. Radioactivity can be from unchanged drugs or incorporated into body constituents, requiring careful interpretation in metabolic studies.
Area of Science:
- Toxicology and Pharmacology
- Biochemistry
- Drug Metabolism
Background:
- Metabolic studies using radiolabeled compounds can lead to misinterpretation.
- Radioactivity detection may indicate unchanged drug, decomposition products, or incorporation into endogenous compounds.
- Differentiating these sources is vital for accurate safety assessment.
Purpose of the Study:
- To highlight the critical importance of distinguishing between direct covalent binding and endogenous incorporation of radioactivity in metabolic studies.
- To illustrate two distinct mechanisms of radioactivity binding using carcinogenic nitroso compounds.
Main Methods:
- Investigated metabolic activation of dimethylnitrosamine and N-methylnitrosourea.
- Examined the formation of reactive methylating intermediates.
- Traced the metabolic fate of formaldehyde and methanol, including incorporation into cellular macromolecules.
Main Results:
- Dimethylnitrosamine requires metabolic activation, while N-methylnitrosourea does not, to form a reactive methylating intermediate.
- This intermediate can alkylate nucleic acids and proteins.
- Metabolites like formaldehyde and methanol can be incorporated into cellular components via normal biosynthetic pathways.
- Alkylation is linked to cytotoxicity, carcinogenesis, and mutagenesis.
Conclusions:
- It is essential to differentiate between covalent binding of foreign chemicals and their metabolites into macromolecules versus incorporation into endogenous compounds.
- Accurate interpretation of radioactivity in metabolic studies is paramount for safety evaluation.
- Understanding these pathways is key to assessing the toxicological risks of xenobiotics.